Handling Risk in Third Party Due Diligence: Corporate Compliance in Pharma
10 Jun 2014 - 10 Jun 2014 - WEBINAR
Pharmaceutical companies operating internationally are hiring a large number of third parties around the world to assist their business. Proper due diligence can make the difference as to whether a third-party relationship is beneficial or unreliable. Compliance and legal experts from leading pharmaceutical companies are going to give their insights and points of view to third party due diligence. Case studies, practical perspectives on risk-based approach, anti-corruption due diligence, in-house procedure of third party due diligence and more will be discussed by leaders from Novartis, Eli Lilly, Celgene or InterMune.